Evidence map›Paper›PMID 31999738›Full record

ArticlePloS one2020

Multi-region assessment of pharmaceutical exposures and predicted effects in USA wadeable urban-gradient streams.

Paul M Bradley, Celeste A Journey, Daniel T Button, Daren M Carlisle, Bradley J Huffman, Sharon L Qi, Kristin M Romanok, Peter C Van Metre

Abstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Review
  3. The presence of antibiotics and multidrug-resistant Staphylococcus aureus reservoir in a low-order stream spring in central Brazil.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Paul M BradleyU.S. Geological Survey, Columbia, South Carolina, United States of America.ORCID 0000-0001-7522-8606
Celeste A JourneyU.S. Geological Survey, Columbia, South Carolina, United States of America.ORCID 0000-0002-2284-5851
Daniel T ButtonU.S. Geological Survey, Columbus, Ohio, United States of America.
Daren M CarlisleU.S. Geological Survey, Lawrence, Kansas, United States of America.
Bradley J HuffmanU.S. Geological Survey, Columbia, South Carolina, United States of America.
Sharon L QiU.S. Geological Survey, Beaverton, Oregon, United States of America.
Kristin M RomanokU.S. Geological Survey, Lawrenceville, New Jersey, United States of America.
Peter C Van MetreU.S. Geological Survey, Austin, Texas, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human-use pharmaceuticals in urban streams link aquatic-ecosystem health to human health. Pharmaceutical mixtures have been widely reported in larger streams due to historical emphasis on wastewater-treatment plant (WWTP) sources, with limited investigation of pharmaceutical exposures and potential effects in smaller headwater streams. In 2014-2017, the United States Geological Survey measured 111 pharmaceutical compounds in 308 headwater streams (261 urban-gradient sites sampled 3-5 times, 47 putative low-impact sites sampled once) in 4 regions across the US. Simultaneous exposures to multiple pharmaceutical compounds (pharmaceutical mixtures) were observed in 91% of streams (248 urban-gradient, 32 low-impact), with 88 analytes detected across all sites and cumulative maximum concentrations up to 36,142 ng/L per site. Cumulative detections and concentrations correlated to urban land use and presence/absence of permitted WWTP discharges, but pharmaceutical mixtures also were common in the 75% of sampled streams without WWTP. Cumulative exposure-activity ratios (EAR) indicated widespread transient exposures with high probability of molecular effects to vertebrates. Considering the potential individual and interactive effects of the detected pharmaceuticals and the recognized analytical underestimation of the pharmaceutical-contaminant (unassessed parent compounds, metabolites, degradates) space, these results demonstrate a nation-wide environmental concern and the need for watershed-scale mitigation of in-stream pharmaceutical contamination.

Indexed as

Environmental ExposureRiversAnimalsEcosystemEnvironmental MonitoringEnvironmental Restoration and RemediationHumansPharmaceutical PreparationsUnited StatesWater Pollutants, ChemicalPharmaceutical PreparationsWater Pollutants, Chemical

Identifiers

PMID31999738
PMCPMC6992211

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.